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 
The bioconjugation of proteins with small molecules has proved an invaluable strategy for 
probing and perturbing biological mechanisms. The general use of chemical methods for protein 
functionalisation can be limited however by the requirement for complicated reaction partners to 
be present in large excess, and harsh conditions which are incompatible with many protein 
scaffolds. Herein we describe a site8selective organocatalyst8mediated protein aldol ligation 
(OPAL) that affords stable carbon8carbon linked bioconjugates at neutral pH. OPAL enables 
rapid modification of proteins using simple aldehyde probes in minimal excess, and is utilised 
here in the affinity tagging of proteins in cell lysate. Furthermore we demonstrate that the β8
hydroxy aldehyde OPAL product can be functionalised again at neutral pH in a tandem 
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organocatalyst8mediated oxime ligation. This tandem strategy is showcased in the ‘chemical 
mimicry’ of a previously inaccessible natural dual post8translationally modified protein integral 
to the pathogenesis of the neglected tropical disease Leishmaniasis. 


 
Protein8small molecule bioconjugates have revolutionised the fields of chemical medicine, 
chemical biology and cell biology 
184
, but their utility can be undermined by the instability of the 
covalent linkages generated by existing protein chemical modification strategies 
5
. Carbon8
carbon bonds, the backbone of all organic molecules, are inherently stable across a range of 
conditions however, and are therefore established as the most coveted linkage in bioconjugation 
studies. Although a small number elegant strategies for the chemical assembly of protein C8C 
bonds, including carbon free8radical additions to alkenes,
6, 7
 Knoevenagel
8
 or Mukaiyama
9
 based 
condensations, and pictet8spengler type ligations,
10
 in addition to other bioorthogonal ligations, 
3, 
11813
 have recently demonstrated impact beyond academic labs the general use of some such 
methods can be hindered by practical limitations. These include the requirement for chemical 
probes containing reactive handles accessible only through multi8step syntheses, or probes 
themselves which are prohibitively expensive and used in large excess, or have reduced 
reactivity under biological conditions such as in the presence of oxygen. Of particular 
significance is the frequent requirement for acidic or basic pH during bioconjugation8 as the 
folding, stability and function of many proteins (and complexes) depends on the maintenance of 
a pH close to neutral. Deviations from this optimal pH window can therefore have deleterious 
effects 
14
 exemplified by the disassembly of the histone octamer nucleosome core 
15
, human 
hemoglobin dissociation 
16
, aggregation of antibodies 
17
 and protein aggregation events 
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associated with neurodegenerative diseases such as Alzheimer’s 
18
 and prion diseases 
19
. Indeed, 
acidic pH is a characteristic feature of the lysosome which facilitates the degradation of proteins. 
There is therefore a pressing need to develop fully biocompatible ligations that address these 
limitations and enable efficient C8C bioconjugation of proteins at neutral pH. Using affordable 
simple probes in ratios acceptable for small molecule chemistry would also allow wider access to 
the methodology in non8specialist labs or those with limited resources. 
In comparison to bioconjugation chemistry the synthesis of C8C bonds in small molecule 
chemistry is well established, and in the 2000’s was redefined by the emergence of 
‘organocatalysts’ 
20, 21
 capable of optimising existing transformations as well as inspiring new 
reactions 
22, 23
. Our interest in this area was piqued by the prominent role aldehyde chemistry has 
played in the exponential development of the field 
24
.  This is notable as aldehydes are chemical 
handles which are easily installed into proteins through modification of both natural 
25, 26
 and 
unnatural amino acids 
27
, with efficiencies akin to the installation of widely utilised protein 
modification tags such as dehydroalanine (from cysteine 
7, 28
 or phosphoserine 
6
) and azides or 
alkynes 
29
. We therefore sought to explore whether the challenges of constructing C8C modified 
proteins could be overcome through exploitation of aldehyde handles, and the development of a 
novel ligation which merged established small molecule aldehyde organocatalysis methods with 
developing bioconjugation chemistry techniques.  
We were attracted to Northrup and Macmillan’s seminal work on cross aldol reactions of 
aldehydes using L8proline  as an organocatalyst 
30
, and the water compatibility of this chemistry 
31
. We envisioned that an analogous cross aldol reaction on protein aldehydes
 might have 
widespread utility because it would enable site selective C8C modification of proteins using 
uncomplicated aldehyde probes and non8toxic affordable organocatalysts. As an additional 
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benefit, we anticipated the β8hydroxy aldehyde product of the cross aldol reaction could be 
subjected to alternative aldehyde ligation conditions to afford dual modified proteins, which are 
of increasing utility 
32
. Herein we disclose the realisation of this strategy in an ‘rganocatalyst8
mediated rotein ldol igation’ (OPAL) that enables site8selective formation of stable C8C 
bonds to protein aldehydes 
at neutral pH at 		
	and at the 8
terminus (Fig. 1, enamine activation mode). OPAL is a stand8alone protein bioconjugation 
reaction which is highly efficient and complete within 1 h using as few as 2 equivalents of 
simple aldehyde probe. Additionally the selectivity of the ligation is also demonstrated in 
complex mixtures through the affinity purification of a pH sensitive protein from a cell lysate.  
Furthermore, we establish that the β8hydroxy aldehyde OPAL product  can subsequently take 
part in an organocatalyst8mediated β8hydroxy oxime ligation unexpectedly accelerated at neutral 
over acidic pH, affording access to dual differentially modified proteins  . The utility of this 
tandem method is showcased in the ‘chemical mimicry’ of a dual post8translationally lipidated  
surface protein, integral to the pathogenesis of Leishmaniasis.
33
 
!

" 
#




#$
$
Schematic representation of organocatalyst8mediated protein aldol ligation (OPAL) and its application.  
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To establish conditions for the OPAL we studied two model protein systems, haem co8factor 
containing horse heart myoglobin %, and disulfide bond containing thioredoxin &, both bearing 
non8enolisable 8terminal α8oxo aldehydes 
34, 35
 (for aldehyde installation methods see 
Supplementary Fig. 1). Preliminary ligations in phosphate buffer (PB) afforded full conversion to 
the desired β8hydroxy protein aldehydes within 6 h at neutral pH with 100 mM L8proline 
organocatalyst , using butyraldehyde ' as an aldol donor (Fig. 2a). Importantly, only a single 
organocatalyst8dependent aldol modification occurred, confirming the expected stability of the 
β8hydroxy aldehyde motif to further aldol reactions 
36
. Additionally UV/Vis spectroscopic 
measurements of the haem group in the modified myoglobin demonstrated no compromise to the 
protein’s tertiary structure had occurred (Supplementary Fig. 2) and trypsin digest and LC8
MS/MS analysis of the resulting peptide fragments confirmed the site8selective nature of OPAL 
(Supplementary Fig. 3).  
 
#$
 $
  Left: OPAL bioconjugations using butyraldehyde ' as an aldol donor and myoglobin % and thioredoxin & as aldol 
acceptors.
Right: Mass spectrum traces of hydrated protein aldehyde starting material, and products following OPAL.  Aldol 
organocatalyst screen using butyraldehyde ' and phenylacetaldehyde (
as donors, with observed second order rate constants for 
individual organocatalysts colour coded red (slowest) < pale orange < dark orange < light green < dark green (fastest). 
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)





Encouraged by the biological compatibility and site8selectivity of these preliminary ligations, 
attention next turned to optimising OPAL by focusing on the choice of organocatalyst and 
aldehyde donor species. We screened a panel of secondary amines to investigate their ability to 
catalyse the ligation using the well studied model peptide substrate α8oxo8aldehyde8LYRAG * 
and butyraldehyde ', and determined second order rate constants for each catalyst at 1, 10, and 
25 mM loadings (Fig. 2b, see Supplementary Table 1, Supplementary Fig. 4 for MS/MS 
analysis, and the Supplementary Information page S35 for a discussion on stereochemistry). 
There was a 608fold range in the magnitude of the rate constants across the panel with tetrazole +

exhibiting the highest value 
37,38
.  Similar reactivity correlations were also evident using a protein 
substrate (Supplementary Fig. 5). Further peptide screens demonstrated that the nature of the α8
carbon substituent of the aldehyde donor also significantly affected the rate of ligation, as in the 
presence of L8proline  and tetrazole +, donors such as phenylacetylaldehyde (, bearing an aryl 
substituent, reacted ~2408fold faster than aldehyde donors bearing alkyl substituents. Overall, the 
rate constant of ~24 M
81
 s
81
 using tetrazole + compares favorably with the fastest aldehyde 
bioconjugations reported in the literature at any pH 
24,39
, demonstrating that judicious choice of 
both organocatalyst and donor species is essential for achieving optimal rates of ligation.  
 
	




Next we set out to explore the scope of these optimised conditions in the site8selective 
bioconjugation of a range of proteins using functionalised α8aryl aldehyde probes. Guided by a 
desire to simplify protein chemical modification procedures, we designed a practical synthetic 
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route to access α8aryl substituted aldehyde donors bearing functional tags, including a 
fluorescent label , a biotin affinity tag , a folate targeting moiety , and
a
bioorthogonal 
azide handle   (Fig. 3a). Probes bearing 1,2 amino8alcohols % were constructed using solid 
phase peptide synthesis (SPPS) from readily available building blocks, and unmasked using a 
biologically compatible periodate oxidation to reveal the desired aldehyde (Fig. 3b). These 
aldehyde probes were then deployed in the site8selective OPAL modification of a variety of α8
oxo aldehyde containing proteins using 25 mM tetrazole +
at neutral pH (Fig. 3c). Thioredoxin, 
myoglobin and hydrophilic acylated surface protein A (HASPA) from 	 
33
, 
all bearing α8oxo aldehydes at their , were modified in quantitative conversion within 1 
h using 2820 equivalents of aldehyde probe, with no modification observed on proteins that did 
not bear the required aldehyde functionality  (see Supplementary Information section 6 for seven 
further protein bioconjugation examples). GFP protein bearing an α8oxo aldehyde in addition to 
a bioorthogonal strained alkyne (cyclooctyne8lysine) at position 39 was also compatible with the 
OPAL conditions and quantitatively modified with both folate (Fig. 3c), and biotin tags (see 
Supplementary Information page S58). Additionally OPAL linkages showed no lability after 
incubation in 25 mM PB pH 7.5 over 72 hours at 37 
o
C (Supplementary Fig. 6).  
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 #$
 $
 
 OPAL probe precursors bearing functional tags.  Mild NaIO4 unmasking of α8aryl aldehyde probes.  OPAL 
functionalization of 8terminal α8oxo aldehyde containing proteins (508250 LM), using probes   (0.581.5 mM).  
 
#




	






We also demonstrated the compatibility of OPAL in bioconjugations at  		 within 
folded green fluorescent protein (GFP) and superfolder GFP (sfGFP) (Fig. 4a, Supplementary 
Fig. 7). α8Oxo aldehydes were first quantitatively installed into the proteins at neutral pH using a 
biocompatible Pd8mediated decaging (1 equivalent for 1 h) 
27
 of an incorporated unnatural 
thiazolidine8lysine (ThzK) amino acid, recently developed in our lab. Both internal aldehydes 
were then functionalised using OPAL to install azide handles at position 39 of GFP and position 
150 of sfGFP in 1 h using aldehyde probe   with no observable loss of fluorescence. 
Furthermore we demonstrated the compatibility of  the Pd8mediated decaging and OPAL 
modification in cell lysate (Fig. 4b, Supplementary Fig. 8810 for uncropped gels).  Following 
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expression of the ThzK containing GFP in  , the cell lysate was subjected to a 1 h Pd8
mediated decaging followed by a further 1 h OPAL using biotin tag 
at neutral pH. The lysate 
was then loaded onto an avidin affinity column, which was washed prior to elution with 2 mM 
biotin to afford the OPAL biotinylated GFP protein (see Supplementary Information page S16 
for protein recovery at each step). The ability to selectively pull8down only the α8oxo aldehyde 
containing GFP from the lysate in a 2 h procedure showcases the selectivity and efficiency of 
OPAL for the modification of an internal aldehyde in folded GFP within a mixture of proteins, 
and the retention of GFP fluorescence (which is quenched at mildly acidic pH 
40
) also highlights 
the significant advantage of functionalisation at neutral pH. 
 
#$
  $
  Incorporation of internal α8oxo aldehydes through Pd8mediated decaging, and tandem OPAL functionalisation of 
proteins. ESI8MS traces of OPAL products following spectra deconvolution.  Pd8mediated decaging and OPAL biotinylation in 
cell lysate. SDS8PAGE Lane 1: ladder; Lane 2: cell lysate post OPAL; Lanes 3, 4, 5: biotin elution.  
)


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As previously observed by Macmillan in small molecule cross aldol reactions
 36
, the β8hydroxy 
aldehyde product of the OPAL displayed no reactivity in further aldol reactions 
41
. So we next 
determined whether this aldehyde was reactive under alternative conditions which would enable 
construction of challenging but coveted differentially bi8functionalised proteins  (Fig. 5), which 
have limitless potential applications 
32,42, 43
. Using peptide β8hydroxy aldehyde8LYRAG &, we 
screened the reactivity of the β8hydroxy aldehyde as an electrophilic partner in two high yielding 
literature bioconjugation reactions, the 	8Pictet8Spengler ligation 
44
 and the 28amino 
benzamidoxime (ABAO) ligation 
45
 (both with optimal reactivity at acidic pH).  Although 
conversion to bi8functionalised product  was observed, yields were disappointingly low 
(Supplementary Fig. 11), emphasising the relative stability of the β8hydroxy aldehyde moiety 
compared to other aldehydes previously used in bioconjugation studies 
25
. We therefore turned 
our attention to the classical acid8catalysed oxime ligation (pH 4.5 optimum), which proceeds 
more slowly at neutral pH but can be accelerated by the addition of aniline ' as an 
organocatalyst 
46
. Gratifyingly, in studies using β8hydroxy aldehyde8LYRAG
& and an 
aminooxy nucleophile at pH 4.5 we achieved 61% conversion to bi8functionalised product * in 
the presence of aniline organocatalyst '. Unexpectedly however, the conversion to the β8
hydroxy oxime product * was further increased to 95% when the reaction was performed at pH 
7.5 (Fig. 5a, aniline schiff base activation mode), which is a reversal of the precedent for oxime 
formation with other aldehyde handles 
46
. This trend was again evident when screening 
alternative aniline organocatalysts which have been previously reported for hydrazone/oxime 
ligation 
47
, as well as with alternative peptide and protein β8hydroxy aldehyde substrates 
(Supplementary Fig. 12), suggesting a general trend in reactivity and improved biological 
compatibility. Akin to observations made for imine formation at 8substituted aromatic 
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aldehydes in water 
48
, this reversal may be governed by intramolecular H8bonding between the 
β8hydroxy group and the protonated aldehyde or aniline Schiff base intermediates formed 
 to oxime formation, and merits further investigation.  
 
,




β-
-


Having established an unexpected reversal in pH dependence for the rate of oxime formation we 
subsequently demonstrated the potential utility of the organocatalyst8mediated β8hydroxy8oxime 
#$
 %$  pH dependence of β8hydroxy oxime ligation using aniline organocatalysts.  Schematic representation of 
organocatalyst8mediated oxime ligation of protein β8hydroxy aldehydes.  Product 
 of tandem organocatalyst8mediated 
bioconjugations of thioredoxin &
and fluorescent OPAL product
, analysed by SDS8PAGE and Western blot.  Product  
of
tandem organocatalyst8mediated bioconjugation of thioredoxin
& analysed by Western blot. Lane 1 in  and 
= molecular weight 
ladder; Lane 2 in  and  = wt thioredoxin, prior to α8oxo aldehyde installation; Lane 3 in  and 
= α8oxo thioredoxin &;
Lane 4
in  and 
= thioredoxin OPAL products;
Lane 5 in  and 
= thioredoxin OPAL8β8hydroxy oxime products.
 Product &
of
tandem organocatalyst8mediated bioconjugations of myoglobin % analysed by SDS8PAGE. Lane 1 = molecular weight ladder; 
Lane 2 = α8oxo myoglobin %; Lane 3 = OPAL8myoglobin %;
Lane 4 = Top band: OPAL8β8hydroxy oxime myoglobin &; 
bottom band: presumed OPAL8myoglobin starting material % with non8covalent association of (. Conditions for tandem β8
hydroxy oxime ligations: proteins 25850 LM, 15 mM + or (, 10 mM , PB (50 mM), pH 7.5, 37 °C, 18842 h. 
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ligation in tandem with OPAL for the construction of dual 8terminal functionalised proteins 
using both a biotin aminooxy affinity handle +, and a polyethylene glycol (PEG) aminooxy 
reagent (
(Fig. 5b). A two8step organocatalyst8mediated tandem modification of thioredoxin & 
was achieved at neutral pH, firstly using OPAL to quantitatively install a fluorescent label into 
the protein using 25 mM tetrazole + and probe , followed by tandem oxime ligation under 
optimised reaction conditions of 10 mM 8anisidine  organocatalyst in PB (50 mM, pH 7.5) 
and biotin affinity handle +,
 to afford differentially functionalised thioredoxin  (Fig. 5c, 
Supplementary Fig. 13 for uncropped gels). SDS8PAGE and Western blot (Anti8biotin8alkaline 
phosphatase antibody detection) analysis of the unmodified α8oxo aldehyde thioredoxin &
(lane 
3), fluorescent OPAL product 
 (lane 4), and the bi8functional construct 
 (lane 5), 
demonstrated that the protein could be detected by fluorescence only after OPAL modification 
with aldehyde probe 
 (lane 4), and by fluorescence and Western blotting only after tandem 
oxime formation using biotin +
(lane 5). Under identical organocatalyst conditions thioredoxin 
could also modified with both an azide and biotin probe with detection of the bi8functionalised 
product   by Western blot (Fig. 5d, Supplementary Fig. 14) as well as myoglobin with both 
azide and biotin (Supplementary Information page S67). Fluorescent myoglobin OPAL product 
% was also further functionalised by PEGylation (Fig. 5e, Supplementary Fig. 15), a strategy 
used for increasing the circulatory lifetime of therapeutic proteins. Following treatment with 
aminooxy probe (, PEGylated fluorescent protein &
 (lane 4)
was
 characterised using SDS8
PAGE by an increase in molecular weight in over both unmodified %
 (lane 2) and fluorescent 
myoglobin %
 (lane 3). Additionally, we noted the β8hydroxy oxime linkages resulting from 
tandem bioconjugation reactions, showed no degradation over 30 days at neutral pH 
(Supplementary Fig. 16).  
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Finally, we sought to explore the suitability of the tandem OPAL8oxime ligation for the 
‘chemical mimicry’ of a natural dual post8translational modification (PTM) integral to the 
pathogenesis of the neglected tropical disease Leishmaniasis. Hydrophilic acylated surface 
proteins (HASPs) are present in all human infective 	 parasites. They are highly 
immunogenic and form the basis of a visceral leishmaniasis vaccine currently undergoing 
clinical trials in humans 
49
. Their expression is stage regulated during human infection, however 
the exact role they play in the parasite lifecycle has yet to be determined 
33
. Non8classically, 
HASPA is dually acylated at the 8terminus (Fig. 6, top) with both myristoyl ' (at Gly1) and 
palmitoyl *
 (at Cys4) lipids, PTMs which are thought to govern its ability to associate with 
plasma membranes 
50
 but not fully rationalised. Whilst co8translational myristoylation of 
HASPA by the parasite 8myristoyl transferase (NMT) can be recapitulated  , the 8
palmitoyltransferase is unknown and the Cys4 containing protein is prone to precipitation, which 
has limited recombinant access to natural dual lipidated protein for further study. We therefore 
designed a strategy using our tandem biocompatible ligations to chemically mimic the structural 
modifications of HASPA for the first time (Fig. 6, bottom), and provide access to a dual lipidated 
construct.  
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 #$
 &$ Schematic representation of native dual PTM of Leishmania HASPA (top), and proposed ‘chemical mimicry’ using 
organocatalyst8mediated tandem bioconjugation (bottom).


Using myristoyl aldehyde + as donor and recombinantly expressed 	  
HASPA bearing an 8terminal α8oxo aldehyde as a substrate (C4S mutant, see Supplementary 
Fig. 17) we firstly used OPAL to construct a chemical mimic ( of the natural myristoylated 
protein at neutral pH in quantitative conversion (ESI8MS characterisation, Fig. 7b). To establish 
that this bioconjugate structurally mimics myristoylation we used NMR spectroscopy to 
characterise both the unmodified HASPA  and enzymatically myristoylated HASPA ', 
lipidated using purified recombinant 8myristoyl transferase 
51
. Following resonance assignment 
of backbone nuclei (Supplementary Fig. 18), comparison of the 2D (
1
H,
15
N) HSQC spectra 
revealed that myristoylation of the native protein caused exchange broadening of resonances for 
residues near the8terminus, including Y3, S4, T5 and S8 (Fig. 7a, left panel). Subsequent NMR 
characterisation of the chemically myristoylated HASPA ( was also then performed and the 
HSQC spectra revealed to be highly comparable to that of the enzymatically modified protein ' 
(Fig. 7a, right panel), with residues near the 8terminus also displaying the characteristic 
exchange broadening following modification. These data therefore demonstrate that OPAL 
modification of HASPA replicates the   solution properties and structure of the 
enzymatically modified protein, and also highlight the simplicity of the OPAL procedure for use 
in the chemical mimicry of protein myristoylation, which in this example requires only three 
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affordable commercial reagents, sodium periodate for aldehyde installation (see Supplementary 
Fig. 1), and aldehyde +
and organocatalyst +
for the OPAL. 
 
#$
'$
 Regions of 2D (1H, 15N) HSQC spectra of [15N]labelled HASPA (C4S mutant). Comparison of unmodified  (grey) 
and enzymatically myristoylated (red) HASPA '
(left). Comparison of unmodified  (grey) and chemically myristoylated (red) 
HASPA (
 (right). (1H,15N) Resonance assignments are indicated. Unassigned peaks are denoted by asterisks.  ESI8MS 
characterisation following spectra deconvolution of chemically myristoylated HASPA (
 (left), and dual modified HASPA 
mimic 
(right), note only peaks for ( and  are visible, in the magnifed spectra on page S83 aldol condensation product with 
loss of H2O is also visible. Notably in all OPAL reactions performed, aldol condensation product is only observed in this 
example.  SDS8PAGE analysis of liposome sedimentation assays over 30h. 20 µg Unmodified HASPA  (left panel), OPAL 
myristoylated HASPA (
 (central panel, myristoylated), and dual modified chemical mimic  HASPA (right panel, dual 
acylated), were added to a suspension of PC:Ch liposomes and dialysed in the presence of detergent and then sedimented. The 
supernantant (S) and resuspended liposome pellet (P) were analyzed by SDS8PAGE (M = molecular weight ladder). See 
Supplementary Figs. 19822 for associated preparation of liposomes, negative controls in the absence of protein or liposome, and 
SDS8PAGE analysis. 
 To begin to investigate the potential function of  dual modification of HASPs, we 
next subjected the OPAL myristoylated HASPA ( to tandem organocatalyst8mediated β8
hydroxy oxime ligation using palmitoyl aminoxy . The dual modified product , a chemical 
mimic of myristoylation and palmitoylation, was also characterised by ESI8MS (Fig. 7b). Finally 
both the OPAL myristoylated HASPA
( and this dual modified HASPA  were characterised 
using time course liposome sedimentation assays to assess their capacity to bind to model 
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biological membranes (Fig. 7c). SDS8PAGE analysis revealed that over a 30 h period both lipid 
modified HASPs displayed substantially greater levels of  association to membranes than 
the unmodified HASPA  (Fig. 7c) and approximately twice as much protein was bound to the 
membrane when HASPA was dual lipidated in  compared to mono myristoylation in ( 
(Supplementary Fig. S22). Results from this   chemical model system’ therefore 
substantiate the notion that the   role of the lipid PTMs is to facilitate attachment of 
HASPA to parasite membranes and determine its localisation to the cell surface 
50
, and 
emphasise that two lipid modifications may be required to maximise  binding, with the 
caveat that further in8depth functional comparison of single and dual lipidated HASPs  
is still warranted.






In conclusion, we have validated the OPAL as a powerful stand8alone C8C forming 
bioconjugation strategy using simple aldehyde probes for the mild site8selective modification of 
a range of proteins at both    		 demonstrating flexibility in both 
positioning and functionalisation. We also demonstrated the compatibility and selectivity of both 
Pd8mediated decaging of internal α8oxo aldehydes and subsequent OPAL modification in a 
mixture of proteins within cell lysate to enable affinity pull8down of GFP, which maintains its 
fluorescence as a consequence of purification at neutral pH. We anticipate the potential 
applicability and simplicity of this strategy may also serve to nucleate further organocatalyst8
mediated protein modification studies.  
In contrast to other protein bioconjugations, OPAL not only ‘survives’ but ‘thrives’ in 
biocompatible conditions. This is because at aqueous neutral pH the β8hydroxy aldehyde product 
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of the OPAL predominates over the enal (aldol condensensation) product. The β8hydroxy group 
of this newly installed aldehyde prevents further aldol reactions facilitating a single site8selective 
modification and in an additional benefit serves as a “pH switch” for a novel tandem β8hydroxy 
oxime ligation which is unexpectedly accelerated at neutral pH over acidic pH.  Oxime ligations 
are perhaps the most widely used protein bioconjugation reaction 
47
,
 
but limited in that they are 
most efficient at acidic pH even when using aniline organocatalysts. The presence of the β8
hydroxy group seemingly alters this acidic bias and constitutes a new aldehyde scaffold for 
bioconjugations, which has an in8built preference to react, and is stable at neutral pH.  
Finally we utilised OPAL in the chemical mimicry of 8terminal myristoylation of a 
HASP protein integral to the pathogenesis of Leishmaniasis and demonstrated the ability to 
mimic the structural effects of enzymatic myristoylation through characterisation by protein 
NMR. Subsequent chemical palmitoylation by a tandem β8hydoxy oxime ligation generated a 
construct that also mimics the previously inaccessible natural dual modified protein, and 
furthermore was used for exploring the effects of single vs. dual lipid modification on binding to 
membranes. Notably this strategy may lend itself to the study of other proteins bearing 
multiple post8translational lipid modifications 
52
 and may also prove broadly applicable in the 
functionalisation and immobilisation of other biomolecules. 
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